Skip to main content
TipRanks
Go Ultimate75% OFF

JEIL PHARMA HOLDINGS INC. (002620) Stock Price & Analysis

002620 Stock Chart & Stats

â‚©6,800.00-â‚©200.00(-2.86%)
At close: 3:30 PM GMT+9
â‚©7Kâ‚©7.5KAug 24Sep 7Sep 21Oct 6Oct 19Nov 2Nov 16
Day’s Range
KRW 6,690.00 - KRW 6,900.00
52-Week Range
KRW 6,050.00 - KRW 9,850.00
Previous Close
KRW 7,000.00
Volume
N/A
Average Volume (3M)
5,369
Market Cap
KRW 104.39B
Enterprise Value
KRW 350.14B
Total Cash (Recent Filing)
KRW 87.50B
Total Debt (Recent Filing)
KRW 184.74B
Price to Earnings (P/E)
12.4
Beta
0.07
Next Earnings
Mar 17, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
1.03%

Bulls Say, Bears Say

Bulls Say

Improving Revenue And Gross Margin

The sharp TTM revenue improvement and higher gross margin indicate better commercial traction and product economics. If sustained, this combination can expand the earnings base and provide more resources for reinvestment, although operating-level profitability still needs to follow.

Manageable Leverage

Moderate leverage and a solid equity position provide a relatively stable financial foundation for a specialty pharmaceutical business. This balance-sheet capacity can help the company fund operations and development while reducing the immediate strain associated with heavier debt burdens.

Return To Positive Profitability

The return to positive net income and ROE marks a meaningful improvement from the losses reported during 2022–2024. Continued profitability would strengthen internal funding capacity and signal that recent commercial and margin improvements are becoming more economically productive.

Bears Say

Negative Free Cash Flow

Negative free cash flow shows that the company is not yet consistently self-funding after investment needs. This can limit financial flexibility, increase reliance on external funding, and make reported earnings less useful as an indicator of durable cash-generating power.

Pressed Core Operating Profitability

Negative EBITDA and slightly negative EBIT indicate that core operations remain loss-making even after the return to positive net income. This raises questions about the durability of earnings and means further revenue or gross-margin gains may be needed before operating profits become dependable.

Unstable Profitability And Rising Debt

A history of large annual losses combined with a recent increase in total debt creates execution risk as the company works to stabilize operations. If operating earnings remain weak, additional debt could become more burdensome and reduce future capital-allocation flexibility.

002620 FAQ

What was JEIL PHARMA HOLDINGS INC.’s price range in the past 12 months?
JEIL PHARMA HOLDINGS INC. lowest stock price was â‚©6050.00 and its highest was â‚©9850.00 in the past 12 months.
What is JEIL PHARMA HOLDINGS INC.’s market cap?
JEIL PHARMA HOLDINGS INC.’s market cap is ₩104.39B.
When is JEIL PHARMA HOLDINGS INC.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were JEIL PHARMA HOLDINGS INC.’s earnings last quarter?
JEIL PHARMA HOLDINGS INC. released its earnings results on Nov 16, 2026. The company reported -â‚©151.727 earnings per share for the quarter.
Is JEIL PHARMA HOLDINGS INC. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does JEIL PHARMA HOLDINGS INC. pay dividends?
JEIL PHARMA HOLDINGS INC. pays a dividend of â‚©70 which represents an annual dividend yield of 1.03%. See more information on JEIL PHARMA HOLDINGS INC. dividends here
What is JEIL PHARMA HOLDINGS INC.’s EPS estimate?
JEIL PHARMA HOLDINGS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JEIL PHARMA HOLDINGS INC. have?
JEIL PHARMA HOLDINGS INC. has 15,973,355 shares outstanding.
What happened to JEIL PHARMA HOLDINGS INC.’s price movement after its last earnings report?
JEIL PHARMA HOLDINGS INC. reported an EPS of -â‚©151.727 in its last earnings report. Following the earnings report the stock price went up 0.429%.
Which hedge fund is a major shareholder of JEIL PHARMA HOLDINGS INC.?
Currently, no hedge funds are holding shares in KR:002620
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology